Melo JV - Search Results

1

Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.

Melo JV, Hochhaus A, Yan XH, Goldman JM. Melo JV, et al. Br J Haematol. 1996 Mar;92(3):684-6. doi: 10.1046/j.1365-2141.1996.00350.x. Br J Haematol. 1996. PMID: 8616036

2

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.

Barnes DJ, Palaiologou D, Panousopoulou E, Schultheis B, Yong AS, Wong A, Pattacini L, Goldman JM, Melo JV. Barnes DJ, et al. Among authors: melo jv. Cancer Res. 2005 Oct 1;65(19):8912-9. doi: 10.1158/0008-5472.CAN-05-0076. Cancer Res. 2005. PMID: 16204063 Free article.

3

BCR-ABL in chronic myelogenous leukemia--how does it work?

Goldman JM, Melo JV. Goldman JM, et al. Among authors: melo jv. Acta Haematol. 2008;119(4):212-7. doi: 10.1159/000140633. Epub 2008 Jun 20. Acta Haematol. 2008. PMID: 18566539 Review.

4

Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism.

Schultheis B, Carapeti-Marootian M, Hochhaus A, Weisser A, Goldman JM, Melo JV. Schultheis B, et al. Among authors: melo jv. Blood. 2002 Mar 1;99(5):1766-75. doi: 10.1182/blood.v99.5.1766. Blood. 2002. PMID: 11861294 Free article.

5

Mutation in the ATP-binding site of BCR-ABL in a patient with chronic myeloid leukaemia with increasing resistance to STI571.

Barthe C, Gharbi MJ, Lagarde V, Chollet C, Cony-Makhoul P, Reiffers J, Goldman JM, Melo JV, Mahon FX. Barthe C, et al. Among authors: melo jv. Br J Haematol. 2002 Oct;119(1):109-11. doi: 10.1046/j.1365-2141.2002.03708.x. Br J Haematol. 2002. PMID: 12358910 Free article.

6

Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate.

Tipping AJ, Deininger MW, Goldman JM, Melo JV. Tipping AJ, et al. Among authors: melo jv. Exp Hematol. 2003 Nov;31(11):1073-80. Exp Hematol. 2003. PMID: 14585372 Free article.

7

Lack of reciprocal translocation in BCR-ABL positive Ph-negative chronic myeloid leukaemia.

Lazaridou A, Chase A, Melo J, Garicochea B, Diamond J, Goldman J. Lazaridou A, et al. Leukemia. 1994 Mar;8(3):454-7. Leukemia. 1994. PMID: 8127150

8

Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.

Melo JV, Goldman JM. Melo JV, et al. Leukemia. 1992 Aug;6(8):786-90. Leukemia. 1992. PMID: 1353550

9

Reply to Haas: Are ABL and BCR imprinted? (Leukemia 1995; 9: 740-743).

Melo JV, Goldman JM. Melo JV, et al. Leukemia. 1995 Aug;9(8):1407-8. Leukemia. 1995. PMID: 7643632 No abstract available.

10

BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.

Diamond J, Goldman JM, Melo JV. Diamond J, et al. Among authors: melo jv. Blood. 1995 Apr 15;85(8):2171-5. Blood. 1995. PMID: 7718887 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters